EP3431076
Bætt lípíðsamsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.6.2010EP published:
6.10.2021EP application number:
18174274.3
EP translation filed:
2.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
9.6.2030Expiry date:
9.6.2026Next due date:
30.6.2026
Title:
IMPROVED LIPID FORMULATION
Timeline
Today
10.6.2010EP application
6.10.2021EP Publication
2.12.2021Translation submitted
15.1.2022Registration published
9.6.2026Expires
Owner
Name:
Arbutus Biopharma CorporationAddress:
100- 8900 Glenlyon Parkway, Burnaby, BC V5J 5J8, CA
Inventor
Name:
AKINC, AkinAddress:
Cambridge, MA Massachusetts 02142, US
Name:
DORKIN, Joseph, R.Address:
Cambridge, MA Massachusetts 02142, US
Name:
QIN, XiaojunAddress:
Cambridge, MA Massachusetts 02142, US
Name:
CANTLEY, WilliamAddress:
Cambridge, MA Massachusetts 02142, US
Name:
MANOHARAN, MuthiahAddress:
Cambridge, MA Massachusetts 02142, US
Name:
RAJEEV, Kallanthottathil, G.Address:
Cambridge, MA Massachusetts 02142, US
Name:
NARAYANANNAIR, Jayaprakash, K.Address:
Cambridge, MA Massachusetts 02142, US
Name:
JAYARAMAN, MuthusamyAddress:
Cambridge, MA Massachusetts 02142, US
Name:
CHEN, JianxinAddress:
Cambridge, MA Massachusetts 02142, US
Name:
ANSELL, StevenAddress:
Cambridge, MA Massachusetts 02142, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
18580009 PDate:
10.6.2009Country:
US
Number:
24483409 PDate:
22.9.2009Country:
US
Classification
Categories:
A61K 9/127, C07C 211/00, A61K 31/20, C12N 5/00, A61K 48/00, A61K 47/50, A61P 9/00, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 6.5.2022
Expires: 9.6.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.5.2023
Expires: 9.6.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.5.2024
Expires: 9.6.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 22.5.2025
Expires: 9.6.2026
Payer: Árnason Faktor ehf.